Rio Tinto, BM, Creo Medical and more What brokers said today - Proactive Investors UK
CREO Stock | 19.25 2.25 13.24% |
Slightly above 55% of Creo Medical's private investors are presently thinking to get in. The analysis of overall sentiment of trading Creo Medical Group stock suggests that some investors are interested at this time. Creo Medical's investing sentiment can be driven by a variety of factors including economic data, Creo Medical's earnings reports, geopolitical events, and overall market trends.
Creo Medical stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Creo daily returns and investor perception about the current price of Creo Medical Group as well as its diversification or hedging effects on your existing portfolios.
Creo |
Rio Tinto, BM, Creo Medical and more What brokers said today Proactive Investors UK
Read at news.google.com
Creo Medical Fundamental Analysis
We analyze Creo Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Creo Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Creo Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
Creo Medical is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Creo Medical Group Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Creo Medical stock to make a market-neutral strategy. Peer analysis of Creo Medical could also be used in its relative valuation, which is a method of valuing Creo Medical by comparing valuation metrics with similar companies.
Peers
Creo Medical Related Equities
HYUD | Hyundai | 3.12 | ||||
SMSD | Samsung Electronics | 2.00 | ||||
0R15 | SoftBank Group | 1.42 | ||||
0QKN | Chocoladefabriken | 1.03 | ||||
SMSN | Samsung Electronics | 0.38 | ||||
0QFP | Gedeon Richter | 0.00 | ||||
0RUK | MOL Hungarian | 0.00 | ||||
0R37 | Berkshire Hathaway | 1.31 | ||||
HSBK | Halyk Bank | 2.27 | ||||
0M69 | OTP Bank | 27.87 |
Additional Tools for Creo Stock Analysis
When running Creo Medical's price analysis, check to measure Creo Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creo Medical is operating at the current time. Most of Creo Medical's value examination focuses on studying past and present price action to predict the probability of Creo Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creo Medical's price. Additionally, you may evaluate how the addition of Creo Medical to your portfolios can decrease your overall portfolio volatility.